公开(公告)号：US20070225280A1

公开(公告)日：2007-09-27

申请号：US11717996

申请日：2007-03-14

Applicant: Kevin William Anderson ,  Nader Fotouhi ,  Paul Gillespie ,  Robert Alan Goodnow ,  Kevin Richard Guertin ,  Nancy-Ellen Haynes ,  Michael Paul Myers ,  Sherrie Lynn Pietranico-Cole ,  Lida Qi ,  Pamela Loreen Rossman ,  Nathan Robert Scott ,  Kshitij Chhabilbhai Thakkar ,  Jefferson Wright Tilley ,  Qiang Zhang

Inventor： Kevin William Anderson ,  Nader Fotouhi ,  Paul Gillespie ,  Robert Alan Goodnow ,  Kevin Richard Guertin ,  Nancy-Ellen Haynes ,  Michael Paul Myers ,  Sherrie Lynn Pietranico-Cole ,  Lida Qi ,  Pamela Loreen Rossman ,  Nathan Robert Scott ,  Kshitij Chhabilbhai Thakkar ,  Jefferson Wright Tilley ,  Qiang Zhang

IPC: A61K31/541 ,  A61K31/496 ,  A61K31/454 ,  A61K31/4196 ,  A61K31/416 ,  C07D403/02 ,  C07D417/02

CPC classification number: C07D403/04 ,  C07D231/12 ,  C07D231/16 ,  C07D231/38 ,  C07D401/04 ,  C07D403/02 ,  C07D407/14 ,  C07D413/04 ,  C07D417/04

Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.

Abstract translation: 本文提供式（I）的化合物及其药学上可接受的盐，其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗疾病，例如II型糖尿病和代谢综合征。

公开(公告)号：US07728029B2

公开(公告)日：2010-06-01

申请号：US11717996

申请日：2007-03-14

Applicant: Kevin William Anderson ,  Nader Fotouhi ,  Paul Gillespie ,  Robert Alan Goodnow, Jr. ,  Kevin Richard Guertin ,  Nancy-Ellen Haynes ,  Michael Paul Myers ,  Sherrie Lynn Pietranico-Cole ,  Lida Qi ,  Pamela Loreen Rossman ,  Nathan Robert Scott ,  Kshitij Chhabilbhai Thakkar ,  Jefferson Wright Tilley ,  Qiang Zhang

Inventor： Kevin William Anderson ,  Nader Fotouhi ,  Paul Gillespie ,  Robert Alan Goodnow, Jr. ,  Kevin Richard Guertin ,  Nancy-Ellen Haynes ,  Michael Paul Myers ,  Sherrie Lynn Pietranico-Cole ,  Lida Qi ,  Pamela Loreen Rossman ,  Nathan Robert Scott ,  Kshitij Chhabilbhai Thakkar ,  Jefferson Wright Tilley ,  Qiang Zhang

IPC: A61K31/4155 ,  A61K31/415 ,  A61K31/454 ,  A61K31/5377 ,  C07D231/14 ,  C07D401/04 ,  C07D413/04 ,  C07D403/04

CPC classification number: C07D403/04 ,  C07D231/12 ,  C07D231/16 ,  C07D231/38 ,  C07D401/04 ,  C07D403/02 ,  C07D407/14 ,  C07D413/04 ,  C07D417/04

Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.

Abstract translation: 本文提供式（I）的化合物及其药学上可接受的盐，其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗疾病，例如II型糖尿病和代谢综合征。